Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice
© Lee et al.; licensee BioMed Central Ltd. 2013
Received: 19 March 2013
Accepted: 27 April 2013
Published: 30 April 2013
Interneuron deficits are one of the most consistent findings in post-mortem studies of schizophrenia patients and are likely important in the cognitive deficits associated with schizophrenia. Disrupted-in-Schizophrenia 1 (DISC1), a strong susceptibility gene for schizophrenia and other mental illnesses, is involved in neurodevelopment, including that of interneurons. However, the mechanism by which DISC1 regulates interneuron development remains unknown. In this study, we analyzed interneuron histology in the Disc1-L100P single point mutation mouse, that was previously shown to have behavioral abnormalities and cortical developmental defects related to schizophrenia.
We sought to determine whether a Disc1-L100P point mutation in the mouse would alter interneuron density and location. First, we examined interneuron position in the developing mouse cortex during embryonic days 14–16 as an indicator of interneuron tangential migration, and found striking migration deficits in Disc1-L100P mutants. Further analysis of adult brains revealed that the Disc1-L100P mutants have selective alterations of calbindin- and parvalbumin-expressing interneurons in the cortex and hippocampus, decreased GAD67/PV co-localization and mis-positioned interneurons across the neocortex when compared to wild-type littermates.
Our results are consistent with the anomalies seen in post-mortem schizophrenia studies and other Disc1 mutant mouse models. Future research is required to determine the specific mechanisms underlying these cellular deficits. Overall, these findings provide further evidence that DISC1 participates in interneuron development and add to our understanding of how DISC1 variants can affect susceptibility to psychiatric illness.
KeywordsDisrupted-in-Schizophrenia 1 (DISC1) Interneuron Mutant mouse Schizophrenia
Cognitive control depends on neural synchrony that maintains a balanced excitation and inhibition in different brain regions. GABAergic interneurons are critical for providing inhibitory control over pyramidal neurons and modulating synchronized oscillations. Interneuron deficits have been one of the most consistent findings in human post-mortem schizophrenia studies, including reductions in glutamic acid decarboxylase-67 (GAD67) expression, and parvalbumin (PV) mRNA expression and immunoreactivity[3–5]. Different interneuron subtypes have distinct electrophysiological and synaptic characteristics. In schizophrenia, GAD67 reduction appears to be restricted to PV-interneurons[7, 8]. This is of particular relevance as recent optogenetic studies on animal models have shown that PV-interneurons are required for generating gamma-frequency oscillations[9, 10], that are critical for cognition[11, 12]. Consistent with this notion, schizophrenia patients display abnormal neural oscillations and synchronizations[13, 14]. Furthermore, rodents with loss of PV-interneurons and impaired gamma activity show selective cognitive deficits reminiscent of schizophrenia symptoms[15, 16].
Disrupted-in-schizophrenia 1 (DISC1) is a strong susceptibility gene for schizophrenia and other mental disorders. DISC1 functions as a scaffold protein and regulates a wide-range of neurodevelopmental processes[18–20]. Different mutant DISC1 mouse models have displayed selective reductions in PV interneurons[21–24] and alterations in their laminar distribution. Recently, Steinecke et al. demonstrated that DISC1 also regulates interneuron tangential migration, further supporting a possible role for DISC1 in modulating interneuron development.
Our group previously described a mutant mouse line, Disc1-L100P that has behavioral and cognitive abnormalities related to schizophrenia, consistent with four other publications. Given the accumulating evidence for DISC1 and interneuron abnormalities in schizophrenia, we undertook a comprehensive histological analysis of interneurons in the Disc1-L100P mutants. Our findings suggest that Disc1 mutations may have distinct spatial and temporal effects in different interneuron subtypes. Overall, our study provides evidence for the effects of Disc1 SNPs on interneuron development that represent a starting point for further investigations into developmental and pathophysiological mechanisms in schizophrenia.
Impaired tangential interneuron position in the embryonic Disc1-L100P mouse
Altered CB- and PV-expressing interneuron numbers in the mPFC and DLFC of Disc1-L100P mutant mice
Aberrant interneuron laminar position in Disc1-L100P mutants
More PV-interneurons located in the lateral neocortex of Disc1-L100P mice
Less GAD67/PV co-localization in Disc1-L100P mice
Increased hippocampal PV-interneurons in Disc1- L100P mutants
There is substantial evidence for an association between DISC1 and several major mental illnesses. However, the mechanism by which DISC1 gene variants produce both cellular and behavioral abnormalities is still unclear. In this study, we examined embryonic interneuron tangential migratory position and adult histology of two interneuron subtypes (CB and PV) in a mouse with a point mutation in the Disc1 gene (L100P), which has been previously shown to have behaviors relevant to schizophrenia.
A recent study suggests that DISC1 is necessary for proper tangential migration of cortical interneurons. Therefore, we examined the tangential migratory pathway of interneurons at E14 and E16, as an indicator of migration. Consistent with the putative role for DISC1 in interneuron development, our study revealed that the Disc1-L100P mutants displayed abnormal tangential migration. This was further supported by our findings that PV-interneurons remained in the lateral adult cortex and that there were fewer interneurons overall in the mPFC. A plausible explanation is that the L100P mutation disrupts specific DISC1 protein interactions and results in mis-regulated downstream signals. ErbB4, and its substrate Neuregulin-1 (NRG1), have been extensively studied for their role in interneuron tangential migration[33–35]. DISC1 has been hypothesized to converge with NRG1-ErbB4 cascades in modulating migration. However, interneuron tangential migration deficits are likely to arise through the simultaneous dysregulation of not just one, but several protein interactions including cytoskeletal proteins, dysbindin, neurotrophins and transcription factors[37–39]. Future research addressing how DISC1 can affect these various pathways will help to elucidate the precise molecular mechanisms by which DISC1 affects interneuron tangential migration.
Next we examined the number and positioning of interneurons in adult Disc1-L100P mice and found changes consistent with human post-mortem schizophrenia studies including reductions in PV immunoreactivity and abnormal laminar distribution patterns[4, 8, 30]. Interestingly, other mutant Disc1 mouse models exhibit similar reductions of PV-interneurons in the PFC and aberrant cortical positioning[21–23]. This suggests that DISC1 protein disruptions may overlap among these different mouse models, with a common effect on interneuron genesis and incorporation of PV-interneurons into proper cortical layers. Interneuron genesis in the ganglionic eminence is likely to be controlled by different transcription factors, but the relationship between DISC1 and interneuron production remains to be determined.
Another theory is based on the pyramidal interneuron network gamma (PING) model, which suggests that PV-interneurons are recruited by glutamatergic inputs from pyramidal neurons. Previously, misplaced cortical pyramidal neurons and reduced spine densities within layers III and V pyramidal neurons were found in the Disc1-L100P mutants. Consequently, incorrect guidance cues and weakened excitatory drive may lead to less recruitment of PV-interneurons and aberrant cortical lamination.
Interestingly, the increase in CB immunoreactivity within the DLFC and PV-immunoreactivity within the CA1 and CA2/3 subfields of the hippocampus did not parallel those observed in post-mortem schizophrenia studies[44–46] and a truncated Disc1 mouse model. Despite the inconsistent findings in the literature, an increase in CB mRNA expression and immunoreactivity in the PFC has been reported in several post-mortem studies[47, 48]. Compared to PV subpopulations, CB-interneurons are less extensively studied and thus their features in schizophrenia remain unclear. CB-interneurons may affect pyramidal neuron activity in a different way than PV-interneurons, since the two interneuron types have different electrophysiological and synaptic characteristics. Furthermore, the increase in CB-interneurons may be a compensatory response to PV-interneuron reductions. Moreover, DISC1 can have differential regional effects between the cortex and hippocampus, as evident from opposing neuronal migration and outgrowth effects in previous DISC1 knockdown studies[49, 50]. Multiple pathways are likely to be involved in determining interneuron fate. Further research is required to elucidate the precise relationship between DISC1-related pathways and to understand the specific roles of DISC1 in different interneuron subpopulations.
As mentioned previously, reduced GAD67 expression in PV-expressing cells has been consistently reported in post-mortem brains of schizophrenia patients[7, 8]. Here, we provide novel evidence of diminished GAD67/PV co-localization in Disc1-L100P mutants when compared to WT controls. Immunohistochemical analyses have confirmed the co-expression of DISC1 and GAD67 in GABAergic interneurons. The Disc1 L100P mutation may affect specific downstream transcription control of GAD67 enzyme levels, or GAD67 reduction may be a compensatory response to reduced PV immunoreactivity. Furthermore, western blots of GAD67 can provide information on whether GAD67 protein levels are changed in our Disc1 mutants. The causes and functional relationship between DISC1 and GAD67 remain to be determined. Our findings provide a starting point for future research to elucidate the role of DISC1 in GABAergic signaling.
As mentioned previously, the immunoreactivity and distribution patterns of PV-immunostained cells have been extensively studied in human post-mortem and animal studies. However, the histological relationship between different interneuron subpopulations has not been examined. Given that our Disc1-L100P mutants displayed selective alterations in density and distribution of both PV- and CB-immunostained cells, future double interneuron immunolabeling experiments would provide important insights about whether the density and distribution of one interneuron subtype is associated with the other.
In conclusion, the results presented in this study support the notion that DISC1 plays a role in interneuron development. But whether DISC1 mutations are a primary cause of aberrant interneuron development through direct disruption of interactions with relevant proteins and transcription factors or produce secondary effects from disturbed pyramidal neuron positioning, remains to be determined. Moreover, investigating electrophysiological properties of the Disc1-L100P mouse cortex and the hippocampus would be useful in addressing functional outcomes of these histological abnormalities. Nonetheless, we have provided an overview of interneuron histology and development in an N-ethyl-N-nitrosourea (ENU)-induced Disc1-L100P mouse line, which supplements our previous work in characterizing cortical abnormalities of pyramidal neurons. Our findings further support the role of DISC1 in interneuron development and provide additional insights about how Disc1 mutations can lead to the brain and cognitive abnormalities associated with schizophrenia. More importantly, this study represents a starting point for further investigation of DISC1-related mechanistic pathways in interneuron development.
N-ethyl-N-nitrosourea (ENU)-mutagenized Disc1-L100P homozygous mutant embryonic and adult mice (8 weeks) on a C57BL/6 background were generated as previously described. WT littermates from the same breeding batch were used as controls. All mouse protocols were approved by the Centre for Addiction and Mental Health Animal Care Committee.
Adult mice were sacrificed by cervical dislocation. Both embryonic and adult mouse brains were dissected, fixed in 4% paraformaldehyde, cryoprotected in 30% sucrose and stored at −80°C before further processing. Frozen coronal sections of 10 μm-thickness were cut using a cryostat (Bright Instrument Co. 5030). All sections were initially incubated in blocking solution (0.1M PBS, 1% Triton X-100, 0.5% Tween 20, 5% skim milk) for 2 hours at room temperature to reduce nonspecific background, followed by primary antibodies overnight at 4°C and secondary antibodies for 2 hours at room temperature. The following primary antibodies were used: anti-parvalbumin (1:200; Sigma-Aldrich), anti-calbindin D-28k (1:200; Millipore) and anti-GAD67 (1:100; Millipore). Fluorescent secondary antibodies conjugated to either Alexa 488 or 594 (1:200; Invitrogen) were used for detection of primary antibodies.
Analysis of immunohistochemistry: interneuron densities and distribution
All immunohistochemical images were captured using a confocal microscope (Zeiss LSM510 Meta) at 10× magnification, converted to grey-scale and normalized to background staining. Sections chosen for analysis were anatomically-matched between comparing groups and included samples from rostral, medial and caudal regions. A two-dimensional cell counting approach was employed, with random sampling from fixed regions of interest (ROI) to provide accurate estimates of cell densities. Fluorescent cells within each ROI were counted using the ITCN plugin for ImageJ (http://rsb.info.nih.gov/ij/) (ITCN parameters: width, 20–25 pixels; minimum distance, 10–13 pixels; threshold, 0.3 pixels)[42, 54]. Anatomical regions were defined according to the Golgi Atlas of the Postnatal Mouse Brain. Specific procedures for defining areas of analysis are described below.
A fixed rectangular ROI was positioned over the mPFC (1 mm high × 500 μm wide) and the DLFC (750 μm high × 1.6 mm) (Figure2A). Similarly for the hippocampus, fixed areas were placed on the dentate gyrus (DG) (300 μm × 600 μm), CA1 and CA2/3 (400 μm × 400 μm) subfields of the hippocampus for analysis of interneuron subtype densities (Figure6A). Only PV-labeled cells were counted in the DG as CB-interneurons were absent. Since CB also labels pyramidal neurons within the hippocampus, CB-labeled interneurons were distinguished and identified on the basis of their location outside the stratum pyramidale cell layer[56, 57].
In the embryonic E14 and E16 brains, a selected curved region (300 μm wide) from the dorsal cortex to ventral preoptic area was outlined, straightened and divided into seven equal ROIs to capture the tangential migratory paths of newborn interneurons (ImageJ) (Figure1A).
Analysis of both laminar and tangential interneuron distribution was performed only in adult brains. Four rectangular ROIs (laminar: fixed width of 800 μm but variable length spanning the thickness of the cortex; tangential: 1 mm high × 800 μm wide) were delineated across the neocortex with the long axis perpendicular to the pial surface (Figure4A). Specifically for laminar distribution analyses, each ROI was further sub-divided into eight equal regions from the pia mater to the bottom edge of layer VI (Figure3A). For all distribution measurements, the number of fluorescently-labeled cells in each bin was counted and expressed as a percentage of the total number within all bins. A percentage rather than absolute counts was used since the exact area covered by the ROI may differ for each brain section, and our objective was to ascertain a shift in distribution across the ROI.
GAD67 and PV colocalization
Fluorescent images for GAD67/PV analysis were taken at 25× magnification. Three fixed square ROIs (350 × 350 μm2) were positioned over each of the two hemispheres across the neocortex. All images were blinded prior to analysis. Co-localization was defined by the experimenter as any overlap in staining. Both the number of GAD67+PV+ and total PV+ cells were counted manually and expressed as a percentage.
Statistical differences between WT and Disc1-L100P mutants were analyzed using the Student’s two-tailed t-test or two-way ANOVA (SPSS 13.0), followed by Bonferroni’s correction for multiple testing. Data are expressed as mean ± standard error of mean (SEM). A significance level of p < 0.05 was used for all analyses.
Dorsolateral frontal cortex
Glutamic acid decarboxylase 67
Medial prefrontal cortex
This work was supported by the Canadian Institutes for Health Research (CIHR), which provided operating funds through a Genomic Medicine and Human Development operating grant GMH79044 and salary support in the form of a Clinician-Scientist Fellowship to AHCW, who also holds a NARSAD Independent Investigator Award and an OMHF Mid-career Investigator Fellowship. CCZ was funded by fellowships from the American Foundation for Suicide Prevention, Eli Lilly, CAMH Foundation. We also thank Carlos Law for blinding of data during analysis. Centre for Addiction and Mental Health, 250 College Street, Room 711, Toronto, Ontario, Canada. M5T 1R8.
- Miller EK, Cohen JD: An integrative theory of prefrontal cortex function. Annu Rev Neurosci. 2001, 24: 167-202. 10.1146/annurev.neuro.24.1.167.View ArticlePubMedGoogle Scholar
- Marin O: Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci. 2012, 13: 107-120.PubMedGoogle Scholar
- Gonzalez-Burgos G, Hashimoto T, Lewis DA: Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep. 2010, 12: 335-344. 10.1007/s11920-010-0124-8.PubMed CentralView ArticlePubMedGoogle Scholar
- Blum BP, Mann JJ: The GABAergic system in schizophrenia. Int J Neuropsychopharmacol. 2002, 5: 159-179.View ArticlePubMedGoogle Scholar
- Lewis DA, Hashimoto T, Volk DW: Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 2005, 6: 312-324. 10.1038/nrn1648.View ArticlePubMedGoogle Scholar
- Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C: Interneurons of the neocortical inhibitory system. Nat Rev Neurosci. 2004, 5: 793-807. 10.1038/nrn1519.View ArticlePubMedGoogle Scholar
- Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE, Jones EG: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995, 52: 258-266. 10.1001/archpsyc.1995.03950160008002.View ArticlePubMedGoogle Scholar
- Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 2003, 23: 6315-6326.PubMedGoogle Scholar
- Cardin JA, Carlen M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai LH, Moore CI: Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature. 2009, 459: 663-667. 10.1038/nature08002.PubMed CentralView ArticlePubMedGoogle Scholar
- Sohal VS, Zhang F, Yizhar O, Deisseroth K: Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009, 459: 698-702. 10.1038/nature07991.PubMed CentralView ArticlePubMedGoogle Scholar
- Haenschel C, Bittner RA, Waltz J, Haertling F, Wibral M, Singer W, Linden DE, Rodriguez E: Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia. J Neurosci. 2009, 29: 9481-9489. 10.1523/JNEUROSCI.1428-09.2009.View ArticlePubMedGoogle Scholar
- Howard MW, Rizzuto DS, Caplan JB, Madsen JR, Lisman J, Aschenbrenner-Scheibe R, Schulze-Bonhage A, Kahana MJ: Gamma oscillations correlate with working memory load in humans. Cereb Cortex. 2003, 13: 1369-1374. 10.1093/cercor/bhg084.View ArticlePubMedGoogle Scholar
- Minzenberg MJ, Firl AJ, Yoon JH, Gomes GC, Reinking C, Carter CS: Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia. Neuropsychopharmacology. 2010, 35: 2590-2599. 10.1038/npp.2010.150.PubMed CentralView ArticlePubMedGoogle Scholar
- Uhlhaas PJ, Singer W: Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010, 11: 100-113. 10.1038/nrn2774.View ArticlePubMedGoogle Scholar
- Lodge DJ, Behrens MM, Grace AA: A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci. 2009, 29: 2344-2354. 10.1523/JNEUROSCI.5419-08.2009.PubMed CentralView ArticlePubMedGoogle Scholar
- Carlen M, Meletis K, Siegle JH, Cardin JA, Futai K, Vierling-Claassen D, Ruhlmann C, Jones SR, Deisseroth K, Sheng M: A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry. 2012, 17: 537-548. 10.1038/mp.2011.31.PubMed CentralView ArticlePubMedGoogle Scholar
- Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, Clair DM, Muir WJ, Blackwood DH, Porteous DJ: Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet. 2000, 9: 1415-1423. 10.1093/hmg/9.9.1415.View ArticlePubMedGoogle Scholar
- Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK: The DISC locus in psychiatric illness. Mol Psychiatry. 2008, 13: 36-64. 10.1038/sj.mp.4002106.View ArticlePubMedGoogle Scholar
- Bradshaw NJ, Porteous DJ: DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology. 2012, 62: 1230-1241. 10.1016/j.neuropharm.2010.12.027.PubMed CentralView ArticlePubMedGoogle Scholar
- Brandon NJ, Sawa A: Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011, 12: 707-722. 10.1038/nrn3120.PubMed CentralView ArticlePubMedGoogle Scholar
- Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andrade M, Tankou S: Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A. 2007, 104: 14501-14506. 10.1073/pnas.0704774104.PubMed CentralView ArticlePubMedGoogle Scholar
- Shen S, Lang B, Nakamoto C, Zhang F, Pu J, Kuan SL, Chatzi C, He S, Mackie I, Brandon NJ: Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci. 2008, 28: 10893-10904. 10.1523/JNEUROSCI.3299-08.2008.View ArticlePubMedGoogle Scholar
- Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim B, Krasnova IN, Sawa A, Margolis RL, Cadet JL, Mori S: Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry. 2011, 16: 293-306. 10.1038/mp.2009.144.PubMed CentralView ArticlePubMedGoogle Scholar
- Niwa M, Kamiya A, Murai R, Kubo K, Gruber AJ, Tomita K, Lu L, Tomisato S, Jaaro-Peled H, Seshadri S: Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron. 2010, 65: 480-489. 10.1016/j.neuron.2010.01.019.PubMed CentralView ArticlePubMedGoogle Scholar
- Steinecke A, Gampe C, Valkova C, Kaether C, Bolz J: Disrupted-in-Schizophrenia 1 (DISC1) is necessary for the correct migration of cortical interneurons. J Neurosci. 2012, 32: 738-745. 10.1523/JNEUROSCI.5036-11.2012.View ArticlePubMedGoogle Scholar
- Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y: Behavioral phenotypes of Disc1 missense mutations in mice. Neuron. 2007, 54: 387-402. 10.1016/j.neuron.2007.04.015.View ArticlePubMedGoogle Scholar
- Marx J: Behavioral genetics. Evidence linking DISC1 gene to mental illness builds. Science. 2007, 318: 1062-1063. 10.1126/science.318.5853.1062.View ArticlePubMedGoogle Scholar
- Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A: Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci. 2009, 32: 485-495. 10.1016/j.tins.2009.05.007.PubMed CentralView ArticlePubMedGoogle Scholar
- Anderson SA, Eisenstat DD, Shi L, Rubenstein JL: Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science. 1997, 278: 474-476. 10.1126/science.278.5337.474.View ArticlePubMedGoogle Scholar
- Beasley CL, Reynolds GP: Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res. 1997, 24: 349-355. 10.1016/S0920-9964(96)00122-3.View ArticlePubMedGoogle Scholar
- Nakajima K: Control of tangential/non-radial migration of neurons in the developing cerebral cortex. Neurochem Int. 2007, 51: 121-131. 10.1016/j.neuint.2007.05.006.View ArticlePubMedGoogle Scholar
- Heckers S, Konradi C: Hippocampal pathology in schizophrenia. Curr Top Behav Neurosci. 2010, 4: 529-553. 10.1007/7854_2010_43.View ArticlePubMedGoogle Scholar
- Yau HJ, Wang HF, Lai C, Liu FC: Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb Cortex. 2003, 13: 252-264. 10.1093/cercor/13.3.252.View ArticlePubMedGoogle Scholar
- Li H, Chou SJ, Hamasaki T, Perez-Garcia CG, O'Leary DD: Neuregulin repellent signaling via ErbB4 restricts GABAergic interneurons to migratory paths from ganglionic eminence to cortical destinations. Neural Dev. 2012, 7: 10-10.1186/1749-8104-7-10.PubMed CentralView ArticlePubMedGoogle Scholar
- Flames N, Long JE, Garratt AN, Fischer TM, Gassmann M, Birchmeier C, Lai C, Rubenstein JL, Marin O: Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron. 2004, 44: 251-261. 10.1016/j.neuron.2004.09.028.View ArticlePubMedGoogle Scholar
- Polleux F, Whitford KL, Dijkhuizen PA, Vitalis T, Ghosh A: Control of cortical interneuron migration by neurotrophins and PI3-kinase signaling. Development. 2002, 129: 3147-3160.PubMedGoogle Scholar
- Batista-Brito R, Rossignol E, Hjerling-Leffler J, Denaxa M, Wegner M, Lefebvre V, Pachnis V, Fishell G: The cell-intrinsic requirement of Sox6 for cortical interneuron development. Neuron. 2009, 63: 466-481. 10.1016/j.neuron.2009.08.005.PubMed CentralView ArticlePubMedGoogle Scholar
- Azim E, Jabaudon D, Fame RM, Macklis JD: SOX6 controls dorsal progenitor identity and interneuron diversity during neocortical development. Nat Neurosci. 2009, 12: 1238-1247. 10.1038/nn.2387.PubMed CentralView ArticlePubMedGoogle Scholar
- Cobos I, Borello U, Rubenstein JL: Dlx transcription factors promote migration through repression of axon and dendrite growth. Neuron. 2007, 54: 873-888. 10.1016/j.neuron.2007.05.024.View ArticlePubMedGoogle Scholar
- Wonders CP, Anderson SA: The origin and specification of cortical interneurons. Nat Rev Neurosci. 2006, 7: 687-696. 10.1038/nrn1954.View ArticlePubMedGoogle Scholar
- Gonzalez-Burgos G, Fish KN, Lewis DA: GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast. 2011, 2011: 723184-PubMed CentralPubMedGoogle Scholar
- Lee FH, Fadel MP, Preston-Maher K, Cordes SP, Clapcote SJ, Price DJ, Roder JC, Wong AH: Disc1 Point Mutations in Mice Affect Development of the Cerebral Cortex. J Neurosci. 2011, 31: 3197-3206. 10.1523/JNEUROSCI.4219-10.2011.View ArticlePubMedGoogle Scholar
- Lewis DA, Curley AA, Glausier JR, Volk DW: Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012, 35: 57-67. 10.1016/j.tins.2011.10.004.PubMed CentralView ArticlePubMedGoogle Scholar
- Benes FM, Kwok EW, Vincent SL, Todtenkopf MS: A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 1998, 44: 88-97. 10.1016/S0006-3223(98)00138-3.View ArticlePubMedGoogle Scholar
- Zhang ZJ, Reynolds GP: A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res. 2002, 55: 1-10. 10.1016/S0920-9964(01)00188-8.View ArticlePubMedGoogle Scholar
- Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB: Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry. 2005, 57: 252-260. 10.1016/j.biopsych.2004.10.019.View ArticlePubMedGoogle Scholar
- Daviss SR, Lewis DA: Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 1995, 59: 81-96. 10.1016/0165-1781(95)02720-3.View ArticlePubMedGoogle Scholar
- Fung SJ, Webster MJ, Sivagnanasundaram S, Duncan C, Elashoff M, Weickert CS: Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry. 2010, 167: 1479-1488. 10.1176/appi.ajp.2010.09060784.View ArticlePubMedGoogle Scholar
- Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y, Sawamura N, Park U, Kudo C, Okawa M: A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol. 2005, 7: 1167-1178. 10.1038/ncb1328.View ArticlePubMedGoogle Scholar
- Duan X, Chang JH, Ge S, Faulkner RL, Kim JY, Kitabatake Y, Liu XB, Yang CH, Jordan JD, Ma DK: Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell. 2007, 130: 1146-1158. 10.1016/j.cell.2007.07.010.PubMed CentralView ArticlePubMedGoogle Scholar
- Meyer KD, Morris JA: Immunohistochemical analysis of Disc1 expression in the developing and adult hippocampus. Gene Expr Patterns. 2008, 8: 494-501. 10.1016/j.gep.2008.06.005.View ArticlePubMedGoogle Scholar
- Mesbah-Oskui L: Place cell activity in Disc1-L100P mutant mice. 2011, Toronto: University of Toronto, Department of PhysiologyGoogle Scholar
- Benes FM, Lange N: Two-dimensional versus three-dimensional cell counting: a practical perspective. Trends Neurosci. 2001, 24: 11-17. 10.1016/S0166-2236(00)01660-X.View ArticlePubMedGoogle Scholar
- Usaj M, Torkar D, Kanduser M, Miklavcic D: Cell counting tool parameters optimization approach for electroporation efficiency determination of attached cells in phase contrast images. J Microsc. 2011, 241: 303-314. 10.1111/j.1365-2818.2010.03441.x.View ArticlePubMedGoogle Scholar
- Valverde F: Golgi Atlas of the Postnatal Mouse Brain. 1998, Austria: Springer Wien New YorkView ArticleGoogle Scholar
- Toth K, Freund TF: Calbindin D28k-containing nonpyramidal cells in the rat hippocampus: their immunoreactivity for GABA and projection to the medial septum. Neuroscience. 1992, 49: 793-805. 10.1016/0306-4522(92)90357-8.View ArticlePubMedGoogle Scholar
- Danglot L, Triller A, Marty S: The development of hippocampal interneurons in rodents. Hippocampus. 2006, 16: 1032-1060. 10.1002/hipo.20225.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.